Pharmaceutical companies, Lundbeck and ACADIA, announced advancements in getting new drugs that treat people with Parkinson’s on the market, while Teva announced a recall affecting a generic Parkinson’s drug. Learn more.
(WASHINGTON, August 22, 2014) – Ronald H. Galowich, chair, and the Parkinson’s Action Network (PAN) Board of Directors announce that Ted Thompson has been selected as its next chief executive officer. He will start on September 8, 2014. Learn more.
On August 15, 2014, PAN joined 38 national organizations representing all ages and disabilities in supporting the Lifespan Respite Care Reauthorization Act (H.R. 4683) and the Military and Veteran Caregiver Services Improvement Act of 2014 (H.R. 4892). Both bills, led by Representative Jim Langevin (D-RI), reauthorize the Lifespan Respite Care Program for $15 million a year for five years. Learn more.
Deloitte published a new whitepaper predicting that 100 million eVisits will happen globally in 2014 and that eVisits could save $5 billion in health care costs compared to regular doctor visits. Learn more.
California Assistant State Director David Higgins, Ph.D., has been named as a patient advocate member of the Independent Citizen’s Oversight Committee (ICOC), the governing board of the California Institute of Regenerative Medicine (CIRM). David will replace Joan Samuelson, PAN’s founder, as the Parkinson’s patient advocate on the board. Learn more.